Notes
The study was funded by Daiichi Sankyo Development Ltd.
Reference
Burton TM, et al. Burden of Illness Associated with Tenosynovial Giant Cell Tumors. Clinical Therapeutics : 23 Mar 2018. Available from: URL: http://doi.org/10.1016/j.clinthera.2018.03.001
Rights and permissions
About this article
Cite this article
Healthcare burden of TGCTs substantial in the US. PharmacoEcon Outcomes News 801, 18 (2018). https://doi.org/10.1007/s40274-018-4873-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4873-7